Polygenic burden in focal and generalized epilepsies
- PMID: 31608925
- PMCID: PMC6821205
- DOI: 10.1093/brain/awz292
Polygenic burden in focal and generalized epilepsies
Erratum in
-
Corrigendum to: Polygenic burden in focal and generalized epilepsies.Brain. 2020 Jul 1;143(7):e61. doi: 10.1093/brain/awaa091. Brain. 2020. PMID: 32268364 Free PMC article. No abstract available.
Abstract
Rare genetic variants can cause epilepsy, and genetic testing has been widely adopted for severe, paediatric-onset epilepsies. The phenotypic consequences of common genetic risk burden for epilepsies and their potential future clinical applications have not yet been determined. Using polygenic risk scores (PRS) from a European-ancestry genome-wide association study in generalized and focal epilepsy, we quantified common genetic burden in patients with generalized epilepsy (GE-PRS) or focal epilepsy (FE-PRS) from two independent non-Finnish European cohorts (Epi25 Consortium, n = 5705; Cleveland Clinic Epilepsy Center, n = 620; both compared to 20 435 controls). One Finnish-ancestry population isolate (Finnish-ancestry Epi25, n = 449; compared to 1559 controls), two European-ancestry biobanks (UK Biobank, n = 383 656; Vanderbilt biorepository, n = 49 494), and one Japanese-ancestry biobank (BioBank Japan, n = 168 680) were used for additional replications. Across 8386 patients with epilepsy and 622 212 population controls, we found and replicated significantly higher GE-PRS in patients with generalized epilepsy of European-ancestry compared to patients with focal epilepsy (Epi25: P = 1.64×10-15; Cleveland: P = 2.85×10-4; Finnish-ancestry Epi25: P = 1.80×10-4) or population controls (Epi25: P = 2.35×10-70; Cleveland: P = 1.43×10-7; Finnish-ancestry Epi25: P = 3.11×10-4; UK Biobank and Vanderbilt biorepository meta-analysis: P = 7.99×10-4). FE-PRS were significantly higher in patients with focal epilepsy compared to controls in the non-Finnish, non-biobank cohorts (Epi25: P = 5.74×10-19; Cleveland: P = 1.69×10-6). European ancestry-derived PRS did not predict generalized epilepsy or focal epilepsy in Japanese-ancestry individuals. Finally, we observed a significant 4.6-fold and a 4.5-fold enrichment of patients with generalized epilepsy compared to controls in the top 0.5% highest GE-PRS of the two non-Finnish European cohorts (Epi25: P = 2.60×10-15; Cleveland: P = 1.39×10-2). We conclude that common variant risk associated with epilepsy is significantly enriched in multiple cohorts of patients with epilepsy compared to controls-in particular for generalized epilepsy. As sample sizes and PRS accuracy continue to increase with further common variant discovery, PRS could complement established clinical biomarkers and augment genetic testing for patient classification, comorbidity research, and potentially targeted treatment.
Keywords: common variant risk; epilepsy; genetic generalized epilepsy; genetics.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.
Figures


Comment in
-
The first step towards personalized risk prediction for common epilepsies.Brain. 2019 Nov 1;142(11):3316-3318. doi: 10.1093/brain/awz318. Brain. 2019. PMID: 31665751 No abstract available.
Similar articles
-
Phenotypic heterogeneity in familial epilepsies is influenced by polygenic risk for generalized and focal epilepsies.Epilepsia. 2025 Jun;66(6):2036-2045. doi: 10.1111/epi.18348. Epub 2025 Mar 6. Epilepsia. 2025. PMID: 40047626 Free PMC article.
-
Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery.EBioMedicine. 2022 Jul;81:104079. doi: 10.1016/j.ebiom.2022.104079. Epub 2022 May 27. EBioMedicine. 2022. PMID: 35636315 Free PMC article.
-
Pleiotropy of polygenic factors associated with focal and generalized epilepsy in the general population.PLoS One. 2020 Apr 28;15(4):e0232292. doi: 10.1371/journal.pone.0232292. eCollection 2020. PLoS One. 2020. PMID: 32343744 Free PMC article.
-
Predictive value of the polygenic risk score for developing epilepsy: a systematic review and meta-analysis.Epilepsy Behav. 2025 Aug;169:110438. doi: 10.1016/j.yebeh.2025.110438. Epub 2025 May 3. Epilepsy Behav. 2025. PMID: 40319673 Review.
-
Genome-Wide Insights and Polygenic Risk Scores in Common Epilepsies: A Narrative Review.Am J Med Genet B Neuropsychiatr Genet. 2025 Jun 13:e33040. doi: 10.1002/ajmg.b.33040. Online ahead of print. Am J Med Genet B Neuropsychiatr Genet. 2025. PMID: 40511554 Review.
Cited by
-
Functional seizures are associated with cerebrovascular disease and functional stroke is more common in patients with functional seizures than epileptic seizures.Epilepsy Behav. 2022 Mar;128:108582. doi: 10.1016/j.yebeh.2022.108582. Epub 2022 Feb 3. Epilepsy Behav. 2022. PMID: 35123242 Free PMC article.
-
Polygenic score analysis identifies distinct genetic risk profiles in Alzheimer's disease comorbidities.Sci Rep. 2025 Apr 3;15(1):11407. doi: 10.1038/s41598-025-95755-8. Sci Rep. 2025. PMID: 40181078 Free PMC article.
-
Investigation of epilepsy-related genes in a Drosophila model.Neural Regen Res. 2026 Jan 1;21(1):195-211. doi: 10.4103/NRR.NRR-D-24-00877. Epub 2024 Dec 16. Neural Regen Res. 2026. PMID: 39688550 Free PMC article.
-
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture.Nat Genet. 2023 Sep;55(9):1471-1482. doi: 10.1038/s41588-023-01485-w. Epub 2023 Aug 31. Nat Genet. 2023. PMID: 37653029 Free PMC article.
-
The genomic landscape across 474 surgically accessible epileptogenic human brain lesions.Brain. 2023 Apr 19;146(4):1342-1356. doi: 10.1093/brain/awac376. Brain. 2023. PMID: 36226386 Free PMC article.
References
-
- Bell GS, Neligan A, Giavasi C, Keezer MR, Novy J, Peacock JL, et al. Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study. J Neurol Neurosurg Psychiatry 2016; 87: 843–50. - PubMed
-
- Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 1991; 41: 965–72. - PubMed
-
- Borodulin K, Tolonen H, Jousilahti P, Jula A, Juolevi A, Koskinen S, et al. Cohort profile: the National FINRISK study. Int J Epidemiol 2017. - PubMed